Understanding Liver Cancer Genetics in African Americans
Genetic Epidemiology of Hepatocellular Carcinoma in African Americans
['FUNDING_R01'] · BAYLOR COLLEGE OF MEDICINE · NIH-11123449
This research looks at genetic factors that might increase the risk of liver cancer in African Americans, aiming to understand why this group has higher rates.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BAYLOR COLLEGE OF MEDICINE (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-11123449 on ClinicalTrials.gov |
What this research studies
Liver cancer is growing quickly in the U.S., and African Americans face twice the risk compared to non-Hispanic whites. Current ways to prevent this cancer haven't fully closed this gap, suggesting that other factors are at play. This project explores whether specific genetic differences might explain why liver cancer is more common in African Americans. By studying the genes of a large group of African American patients with liver cancer, we hope to find new ways to predict who is at risk and develop better prevention strategies.
Who could benefit from this research
Good fit: This research focuses on African Americans with hepatocellular carcinoma (HCC) and those at risk, particularly within the state of Texas.
Not a fit: Patients who are not of African American descent or who do not have hepatocellular carcinoma may not directly benefit from this specific genetic risk factor research.
Why it matters
Potential benefit: If successful, this work could lead to better ways to identify African Americans at higher risk for liver cancer, allowing for earlier screening and more targeted prevention efforts.
How similar studies have performed: Genome-wide association studies have successfully identified genetic risk factors for liver cancer in European and Asian populations, suggesting a similar approach could be fruitful for African Americans.
Where this research is happening
HOUSTON, UNITED STATES
- BAYLOR COLLEGE OF MEDICINE — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: THRIFT, AARON PETER — BAYLOR COLLEGE OF MEDICINE
- Study coordinator: THRIFT, AARON PETER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.